MX2015008369A - Composiciones de diclofenaco. - Google Patents

Composiciones de diclofenaco.

Info

Publication number
MX2015008369A
MX2015008369A MX2015008369A MX2015008369A MX2015008369A MX 2015008369 A MX2015008369 A MX 2015008369A MX 2015008369 A MX2015008369 A MX 2015008369A MX 2015008369 A MX2015008369 A MX 2015008369A MX 2015008369 A MX2015008369 A MX 2015008369A
Authority
MX
Mexico
Prior art keywords
diclofenac
composition
present
diclofenac composition
articular
Prior art date
Application number
MX2015008369A
Other languages
English (en)
Other versions
MX365375B (es
Inventor
Dinesh Shantilal Patel
Sachin Dinesh Patel
Shashikant Prabhudas Kurani
Madhavlal Govindlal Patel
Original Assignee
Themis Medicare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54198802&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015008369(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Themis Medicare Ltd filed Critical Themis Medicare Ltd
Publication of MX2015008369A publication Critical patent/MX2015008369A/es
Publication of MX365375B publication Critical patent/MX365375B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición que comprende diclofenaco y sales del mismo, en la que el diclofenaco o sus sales están presentes en una cantidad de 25 a 200 mg. La composición es adecuada para la administración parenteral por vía intramuscular, pintravenosa; también para administración oral, dérmica, subcutánea, cutánea, nasal, gotas oftálmicas, así como supositorios rectales, óvulos vaginales, administración intraarticular y ótica. La invención también proporciona composiciones que comprenden una combinación de diclofenaco y otros principios activos. La invención también proporciona un método para preparar la composición.
MX2015008369A 2012-12-28 2013-12-27 Composiciones de diclofenaco. MX365375B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3704MU2012 2012-12-28
PCT/IN2013/000805 WO2014102824A1 (en) 2012-12-28 2013-12-27 Diclofenac composition

Publications (2)

Publication Number Publication Date
MX2015008369A true MX2015008369A (es) 2016-03-01
MX365375B MX365375B (es) 2019-05-31

Family

ID=54198802

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015008369A MX365375B (es) 2012-12-28 2013-12-27 Composiciones de diclofenaco.

Country Status (25)

Country Link
US (1) US20140187635A1 (es)
EP (1) EP2938325B8 (es)
JP (1) JP6117939B2 (es)
KR (1) KR101730284B1 (es)
CN (1) CN104968331A (es)
AP (1) AP2015008534A0 (es)
AU (1) AU2013368849B2 (es)
BR (1) BR112015015699B1 (es)
CL (1) CL2015001869A1 (es)
EA (1) EA035079B1 (es)
ES (1) ES2721400T3 (es)
HK (1) HK1211858A1 (es)
HU (1) HUE045030T2 (es)
IL (1) IL239395A0 (es)
MA (1) MA38292A1 (es)
MX (1) MX365375B (es)
MY (1) MY184886A (es)
PE (1) PE20151208A1 (es)
PH (1) PH12015501479A1 (es)
SG (1) SG11201504577UA (es)
SI (1) SI2938325T1 (es)
TR (1) TR201905806T4 (es)
UA (1) UA114123C2 (es)
WO (1) WO2014102824A1 (es)
ZA (1) ZA201504258B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101524473B1 (ko) * 2014-12-22 2015-06-02 주식회사 한국팜비오 주사제 조성물
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
US11110073B2 (en) 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
GB201720992D0 (en) * 2017-12-15 2018-01-31 Hooper Mark A medical use
GR1009729B (el) * 2018-08-02 2020-05-15 Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια Σταθερος ενεσιμος συνδυασμος
KR20210093256A (ko) * 2018-11-16 2021-07-27 세이가가쿠 고교 가부시키가이샤 의약 조성물
US20220280463A1 (en) 2019-09-09 2022-09-08 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
TW202140062A (zh) * 2020-02-18 2021-11-01 丹麥商諾佛 儂迪克股份有限公司 Ｇｌｐ－１組成物及其用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324193A1 (de) 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
DE3446873A1 (de) 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
EP0661050A1 (en) * 1991-07-04 1995-07-05 Taisho Pharmaceutical Co. Ltd Analgesic
US5389681A (en) 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
AU2004226323A1 (en) * 2003-03-26 2004-10-14 Becton, Dickinson And Company Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection
WO2005027977A2 (en) 2003-09-22 2005-03-31 Agis Industries (1983) Ltd. Diclofenac compositions for the treatment of skin disorders
US20050238674A1 (en) 2004-03-10 2005-10-27 Shimoda Biotech (Pty) Ltd. Stable injectable compositions
US20050214230A1 (en) * 2004-03-23 2005-09-29 J. B. Chemicals & Pharmaceuticals Ltd. Novel stomatological gel
US8809393B2 (en) * 2005-02-01 2014-08-19 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenac and its pharmaceutically acceptable salts
KR20080016689A (ko) * 2005-05-27 2008-02-21 파나세아 바이오테크 리미티드 약물주사가 가능한 새로운 형태의 조성물 및 이러한조성물을 위한 조제방법
EA201100863A1 (ru) 2008-11-28 2011-12-30 Эдванс Холдингз Лимитед Фармацевтическая композиция, включающая диклофенак и сложный эфир гидроксижирной кислоты и полиоксиалкилена

Also Published As

Publication number Publication date
MA38292A1 (fr) 2017-06-30
WO2014102824A1 (en) 2014-07-03
CL2015001869A1 (es) 2015-10-23
SI2938325T1 (sl) 2019-06-28
EP2938325A1 (en) 2015-11-04
PH12015501479B1 (en) 2015-09-21
PE20151208A1 (es) 2015-08-23
JP6117939B2 (ja) 2017-04-19
AP2015008534A0 (en) 2015-06-30
PH12015501479A1 (en) 2015-09-21
EP2938325B1 (en) 2019-04-10
UA114123C2 (xx) 2017-04-25
HK1211858A1 (en) 2016-06-03
EA035079B1 (ru) 2020-04-24
ES2721400T3 (es) 2019-07-31
WO2014102824A8 (en) 2014-10-02
TR201905806T4 (tr) 2019-05-21
AU2013368849B2 (en) 2017-01-12
ES2721400T8 (es) 2019-10-10
MY184886A (en) 2021-04-29
JP2016508139A (ja) 2016-03-17
EP2938325B8 (en) 2019-09-25
KR20150090250A (ko) 2015-08-05
CN104968331A (zh) 2015-10-07
SG11201504577UA (en) 2015-07-30
US20140187635A1 (en) 2014-07-03
ZA201504258B (en) 2016-04-28
IL239395A0 (en) 2015-07-30
HUE045030T2 (hu) 2019-12-30
MX365375B (es) 2019-05-31
BR112015015699B1 (pt) 2022-09-27
KR101730284B1 (ko) 2017-04-25
EA201591230A1 (ru) 2015-11-30
AU2013368849A1 (en) 2015-07-09
BR112015015699A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
PH12015501479A1 (en) Diclofenac composition
MX2022007264A (es) Mejoramiento de autofagia o incremento de longevidad por administracion de urolitinas o precursores de las mismas.
NZ631537A (en) Compositions and methods for modulating apolipoprotein c-iii expression
MX2020003805A (es) Sistemas de deposito que comprende glatiramer o una sal farmacologicamente aceptable del mismo.
TN2012000369A1 (en) 5-alkynyl-pyrimidines
UA114656C2 (uk) Похідні піридину
NZ709958A (en) Enhanced stability of novel liquid compositions
WO2013067199A3 (en) Subcutaneous delivery of polymer conjugates of therapeutic agents
SG10201810928SA (en) Novel antitumoral use of cabazitaxel
MX2014003025A (es) Compuestos de triazolopiridina como inhibidores de fosfodiesterasa 10a.
MX2013002329A (es) Agonista de receptores de neutrofina y sus usos como medicamentos.
GB2518813A (en) OMV vaccine against Burkholderia infections
PH12014502571A1 (en) Ophthalmic compositions with improved dessication protection and retention
PH12016501879A1 (en) Immunological composition containing attenuated histophilus somni
MD20140123A2 (ro) Agenţi terapeutici optimizaţi pentru administrare subcutanată
BR112014002173A2 (pt) proteínas purificadas
MX337464B (es) Profarmacos lipofilicos labiles al acido de los agentes quimioterapeuticos contra el cancer.
MX2016003238A (es) Composiciones antisepticas cationicas.
MY160383A (en) Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
MX2012006265A (es) Formulaciones disacaridas hipersulfatadas.
MX2015007794A (es) Suministro transmucosal de acetato de glatiramer mediante parches orales.
WO2014093818A3 (en) Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
MX2015001007A (es) Composicion de misoprostol.
MX2016001912A (es) Metodos para tratar infecciones oticas luego de la colocacion de un tubo de timpanostomia.

Legal Events

Date Code Title Description
FG Grant or registration